drugset / Trial / NCT00671424

A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide

NCT00671424

Phase 1 Completed 48 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

Many patients with type 2 diabetes also have conditions that are treated with diuretics. The patients may also be treated with GSK189075 for their diabetes. This study is planned to assess possible effects of administering GSK189075 in combination with two frequently used diuretics.

Timeline

Start
2008-03
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified
Subject Hydrochlorothiazide Unknown
Subject remogliflozin etabonate Small molecule